PT3632909T - Sal e forma cristalina de composto de andrografólido modificado e seu método de preparação - Google Patents
Sal e forma cristalina de composto de andrografólido modificado e seu método de preparaçãoInfo
- Publication number
- PT3632909T PT3632909T PT188058937T PT18805893T PT3632909T PT 3632909 T PT3632909 T PT 3632909T PT 188058937 T PT188058937 T PT 188058937T PT 18805893 T PT18805893 T PT 18805893T PT 3632909 T PT3632909 T PT 3632909T
- Authority
- PT
- Portugal
- Prior art keywords
- salt
- modified
- preparation
- crystal form
- andrographolide compound
- Prior art date
Links
- 239000013078 crystal Chemical group 0.000 title 1
- -1 modified andrographolide compound Chemical class 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 150000003839 salts Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710373576 | 2017-05-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3632909T true PT3632909T (pt) | 2023-09-27 |
Family
ID=64396260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT188058937T PT3632909T (pt) | 2017-05-24 | 2018-05-24 | Sal e forma cristalina de composto de andrografólido modificado e seu método de preparação |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11299482B2 (pt) |
| EP (1) | EP3632909B1 (pt) |
| CN (1) | CN110650953B (pt) |
| ES (1) | ES2955294T3 (pt) |
| PT (1) | PT3632909T (pt) |
| WO (1) | WO2018214929A1 (pt) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3209658A1 (en) | 2014-10-24 | 2017-08-30 | Biogen MA Inc. | Diterpenoid derivatives and methods of use thereof |
| CN105367558B (zh) | 2015-08-27 | 2018-07-03 | 沈阳药科大学 | 穿心莲内酯衍生物及其制备方法和用途 |
| CN106800551B (zh) | 2015-11-26 | 2021-05-11 | 黑龙江珍宝岛药业股份有限公司 | 穿心莲内酯改构化合物 |
| WO2017088738A1 (zh) | 2015-11-26 | 2017-06-01 | 南京明德新药研发股份有限公司 | 穿心莲内酯改构化合物 |
-
2018
- 2018-05-24 EP EP18805893.7A patent/EP3632909B1/en active Active
- 2018-05-24 ES ES18805893T patent/ES2955294T3/es active Active
- 2018-05-24 PT PT188058937T patent/PT3632909T/pt unknown
- 2018-05-24 CN CN201880033723.8A patent/CN110650953B/zh active Active
- 2018-05-24 US US16/616,300 patent/US11299482B2/en active Active
- 2018-05-24 WO PCT/CN2018/088168 patent/WO2018214929A1/zh not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3632909A1 (en) | 2020-04-08 |
| CN110650953B (zh) | 2023-01-10 |
| EP3632909B1 (en) | 2023-07-12 |
| EP3632909A4 (en) | 2020-12-23 |
| US20210284630A1 (en) | 2021-09-16 |
| WO2018214929A1 (zh) | 2018-11-29 |
| US11299482B2 (en) | 2022-04-12 |
| ES2955294T3 (es) | 2023-11-29 |
| CN110650953A (zh) | 2020-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202007037B (en) | Crystal form of c-met inhibitor and salt form thereof and preparation method therefor | |
| EP3287444A4 (en) | New crystal form of lenvatinib methanesulfonate salt and preparation method thereof | |
| GB201514756D0 (en) | Compound and method of use | |
| PT3470400T (pt) | Formas cristalinas de ozanimod e cloridrato de ozanimod, e processos para a preparação das mesmas | |
| IL250290A0 (en) | A salt of a monocyclic pyridine derivative and its crystalline form | |
| IL252691B (en) | A method of producing crystals of a diazabicyclooctane derivative and a stable lyophilized preparation | |
| EP3502100A4 (en) | CRYSTAL FORMS OF OZANIMOD AND MANUFACTURING METHOD THEREFOR | |
| IL272108A (en) | New crystal structures of vilanterol tripentate and processes for their preparation | |
| EP3239149A4 (en) | Crystal form i of canagliflozin and preparation method thereof | |
| ZA202003581B (en) | Crystal form of urat1 inhibitor, and preparation method therefor | |
| EP3272751A4 (en) | Crystal form of ipi-145 and preparation method thereof | |
| EP3302099A4 (en) | Enhanced salt compositions and methods of preparation thereof | |
| ZA202004055B (en) | Salt of phenylpropionamide derivative and preparation method therefor | |
| PL3327012T3 (pl) | Krystaliczne postacie bilastyny i sposoby ich wytwarzania | |
| IL254709B (en) | Methods for the use and production of innovative and useful salt for food | |
| PT3725786T (pt) | Forma cristalina e forma salina de inibidor de tgf-bri e método de preparação das mesmas | |
| EP3369733A4 (en) | Crystal form of 4h-pyrazolo[1,5- ]benzoimidazole compound, preparation method therefor and intermediate thereof | |
| PL3330267T3 (pl) | Sól pochodnej chinazoliny lub jej kryształ oraz sposób wytwarzania soli pochodnej chinazoliny lub jej kryształu | |
| PL3115365T3 (pl) | Nowa sól skondensowanego związku pirymidynowego i jej kryształ | |
| IL274274A (en) | Salt form and crystal form of compound as FGFR4 inhibitor and method of their preparation | |
| ZA202101589B (en) | Crystal form of tri-cycle compound and application thereof | |
| IL263868A (en) | Crystal structures of aminomethyl-converted tetracyclines and processes for their preparation | |
| EP3269710A4 (en) | Nintedanib diethanesulfonate salt crystal and preparation method and use thereof | |
| PL3692127T3 (pl) | Substancje pro-zapachowe i sposób ich wytwarzania | |
| IL258451A (en) | Salt type and crystal type of h4-pyrazole [5,1-alpha] compound benzimidazole and its method of preparation and intermediate |